Search Tag: Genomics

2024 03 Nov

  Lung cancer remains one of the most prevalent forms of cancer globally and is the leading cause of cancer-related mortality. Despite advancements in medical research, the overall survival (OS) rate for lung cancer patients continues to be low, underlining the urgent need for more accurate diagnostic and prognostic tools. When used separately,...Read more

2020 19 Oct

Five years ago, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and National Cancer Institute (NCI), part of the National Institutes of Health, jointly launched the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131), the largest precision medicine cancer trial to date. The objective was to match genetic abnormalities driving patients'...Read more